Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury

John A. Kellum; Norbert Lameire; Peter Aspelin; Rashad S. Barsoum; Emmanuel A. Burdmann; Stuart L. Goldstein; Charles A. Herzog; Michael Joannidis; Andreas Kribben; Andrew S. Levey; Alison M. MacLeod; Ravindra L. Mehta; Patrick T. Murray; Saraladevi Naicker; Steven M. Opal; Franz Schaefer; Miet Schetz; Shigehiko Uchino

doi:10.1038/kisup.2012.1

Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury

John A. Kellum
, Norbert Lameire
, Peter Aspelin
, Rashad S. Barsoum
, Emmanuel A. Burdmann
, Stuart L. Goldstein
, Charles A. Herzog
, Michael Joannidis
, Andreas Kribben
, Andrew S. Levey
, Alison M. MacLeod
, Ravindra L. Mehta
, Patrick T. Murray
, Saraladevi Naicker
, Steven M. Opal
, Franz Schaefer
, Miet Schetz
, Shigehiko Uchino

Medicine - Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

2983 Scopus citations

Abstract

The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Acute Kidney Injury (AKI) aims to assist practitioners caring for adults and children at risk for or with AKI, including contrast-induced acute kidney injury (CI-AKI). Guideline development followed an explicit process of evidence review and appraisal. The guideline contains chapters on definition, risk assessment, evaluation, prevention, and treatment. Definition and staging of AKI are based on the Risk, Injury, Failure; Loss, End-Stage Renal Disease (RIFLE) and Acute Kidney Injury Network (AKIN) criteria and studies on risk relationships. The treatment chapters cover pharmacological approaches to prevent or treat AKI, and management of renal replacement for kidney failure from AKI. Guideline recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Limitations of the evidence are discussed and specific suggestions are provided for future research.

Original language	English (US)
Pages (from-to)	1-138
Number of pages	138
Journal	Kidney International Supplements
Volume	2
Issue number	1
DOIs	https://doi.org/10.1038/kisup.2012.1
State	Published - Mar 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Clinical Practice Guideline
KDIGO
acute kidney injury
contrast-induced nephropathy
evidence-based recommendation
renal replacement therapy

Publisher link

10.1038/kisup.2012.1

https://kdigo.org/guidelines/acute-kidney-injury/License: Unspecified

Find It

Find It at U of M Libraries

Cite this

Kellum, J. A., Lameire, N., Aspelin, P., Barsoum, R. S., Burdmann, E. A., Goldstein, S. L., Herzog, C. A., Joannidis, M., Kribben, A., Levey, A. S., MacLeod, A. M., Mehta, R. L., Murray, P. T., Naicker, S., Opal, S. M., Schaefer, F., Schetz, M., & Uchino, S. (2012). Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements, 2(1), 1-138. https://doi.org/10.1038/kisup.2012.1

Kellum, JA, Lameire, N, Aspelin, P, Barsoum, RS, Burdmann, EA, Goldstein, SL, Herzog, CA, Joannidis, M, Kribben, A, Levey, AS, MacLeod, AM, Mehta, RL, Murray, PT, Naicker, S, Opal, SM, Schaefer, F, Schetz, M & Uchino, S 2012, 'Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury', Kidney International Supplements, vol. 2, no. 1, pp. 1-138. https://doi.org/10.1038/kisup.2012.1

@article{aea06425fa1748bdbfb49d75c4eaf614,

title = "Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury",

abstract = "The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Acute Kidney Injury (AKI) aims to assist practitioners caring for adults and children at risk for or with AKI, including contrast-induced acute kidney injury (CI-AKI). Guideline development followed an explicit process of evidence review and appraisal. The guideline contains chapters on definition, risk assessment, evaluation, prevention, and treatment. Definition and staging of AKI are based on the Risk, Injury, Failure; Loss, End-Stage Renal Disease (RIFLE) and Acute Kidney Injury Network (AKIN) criteria and studies on risk relationships. The treatment chapters cover pharmacological approaches to prevent or treat AKI, and management of renal replacement for kidney failure from AKI. Guideline recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Limitations of the evidence are discussed and specific suggestions are provided for future research.",

keywords = "Clinical Practice Guideline, KDIGO, acute kidney injury, contrast-induced nephropathy, evidence-based recommendation, renal replacement therapy",

author = "Kellum, \{John A.\} and Norbert Lameire and Peter Aspelin and Barsoum, \{Rashad S.\} and Burdmann, \{Emmanuel A.\} and Goldstein, \{Stuart L.\} and Herzog, \{Charles A.\} and Michael Joannidis and Andreas Kribben and Levey, \{Andrew S.\} and MacLeod, \{Alison M.\} and Mehta, \{Ravindra L.\} and Murray, \{Patrick T.\} and Saraladevi Naicker and Opal, \{Steven M.\} and Franz Schaefer and Miet Schetz and Shigehiko Uchino",

year = "2012",

month = mar,

doi = "10.1038/kisup.2012.1",

language = "English (US)",

volume = "2",

pages = "1--138",

journal = "Kidney International Supplements",

issn = "2157-1724",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - Kidney disease

T2 - Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury

AU - Kellum, John A.

AU - Lameire, Norbert

AU - Aspelin, Peter

AU - Barsoum, Rashad S.

AU - Burdmann, Emmanuel A.

AU - Goldstein, Stuart L.

AU - Herzog, Charles A.

AU - Joannidis, Michael

AU - Kribben, Andreas

AU - Levey, Andrew S.

AU - MacLeod, Alison M.

AU - Mehta, Ravindra L.

AU - Murray, Patrick T.

AU - Naicker, Saraladevi

AU - Opal, Steven M.

AU - Schaefer, Franz

AU - Schetz, Miet

AU - Uchino, Shigehiko

PY - 2012/3

Y1 - 2012/3

N2 - The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Acute Kidney Injury (AKI) aims to assist practitioners caring for adults and children at risk for or with AKI, including contrast-induced acute kidney injury (CI-AKI). Guideline development followed an explicit process of evidence review and appraisal. The guideline contains chapters on definition, risk assessment, evaluation, prevention, and treatment. Definition and staging of AKI are based on the Risk, Injury, Failure; Loss, End-Stage Renal Disease (RIFLE) and Acute Kidney Injury Network (AKIN) criteria and studies on risk relationships. The treatment chapters cover pharmacological approaches to prevent or treat AKI, and management of renal replacement for kidney failure from AKI. Guideline recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Limitations of the evidence are discussed and specific suggestions are provided for future research.

AB - The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Acute Kidney Injury (AKI) aims to assist practitioners caring for adults and children at risk for or with AKI, including contrast-induced acute kidney injury (CI-AKI). Guideline development followed an explicit process of evidence review and appraisal. The guideline contains chapters on definition, risk assessment, evaluation, prevention, and treatment. Definition and staging of AKI are based on the Risk, Injury, Failure; Loss, End-Stage Renal Disease (RIFLE) and Acute Kidney Injury Network (AKIN) criteria and studies on risk relationships. The treatment chapters cover pharmacological approaches to prevent or treat AKI, and management of renal replacement for kidney failure from AKI. Guideline recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Limitations of the evidence are discussed and specific suggestions are provided for future research.

KW - Clinical Practice Guideline

KW - KDIGO

KW - acute kidney injury

KW - contrast-induced nephropathy

KW - evidence-based recommendation

KW - renal replacement therapy

UR - https://www.scopus.com/pages/publications/84884342549

UR - https://www.scopus.com/pages/publications/84884342549#tab=citedBy

U2 - 10.1038/kisup.2012.1

DO - 10.1038/kisup.2012.1

M3 - Editorial

AN - SCOPUS:84884342549

SN - 2157-1724

VL - 2

SP - 1

EP - 138

JO - Kidney International Supplements

JF - Kidney International Supplements

IS - 1

ER -

Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury

Abstract

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this